Advertisement
Screener

NEUROPACE, INC. (NPCE) Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized

3.4 / 5 stars · 13/19 Roast Me

NEUROPACE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized

NEUROPACE, INC. (NPCE) reported Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized of 2.90 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-10.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized · last filed 2022-03-10

  • NEUROPACE, INC. share-based compensation arrangement by share-based payment award, number of additional shares authorized for the quarter ending 2021-12-31 was 0.00 shares.
  • NEUROPACE, INC. share-based compensation arrangement by share-based payment award, number of additional shares authorized for the quarter ending 2021-09-30 was 0.00 shares.
  • NEUROPACE, INC. share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2021 was 2.90M shares, a 19.26% decline from fiscal 2020.
  • NEUROPACE, INC. share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2020 was 3.59M shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 12 month
2021-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
0.00 shares
derived: sum of 2 quarters · filed 2022-03-10
2.90M shares
10-K · filed 2022-03-10
2021-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
2.90M shares
10-Q · filed 2021-11-10
2021-06-302.90M shares
10-Q · filed 2021-08-12
2020-12-313.59M shares
10-K · filed 2022-03-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
CERUS CORP (CERS)United States$0.525B-86.40
CARLSMED, INC. (CARL)United States$0.405B
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
Orthofix Medical Inc. (OFIX)$0.373B
SS Innovations International, Inc. (SSII)$0.589B-64.06
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39